Follistatin and omega-3: separating gym lore from actual biology

What did @ali_abughaben actually say?

Honestly, the transcript here is nearly incomprehensible, likely a machine-translation artifact from Arabic. The caption tells us more than the transcript does: the video is about follistatin, and a previous question apparently linked it to omega-3. The creator seems to be positioning follistatin as something related to growth hormone, possibly describing it as a powerful or "limitless" growth-related compound. The hashtags include "steroid" and "gym," which gives us a reasonable idea of the audience and framing.

Because the transcript is garbled beyond usable quotes, this fact-check focuses on the claims most commonly made about follistatin in fitness and peptide communities, which is almost certainly what this video covers given the context. That framing, calling follistatin a kind of endless or limitless growth hormone, is the core claim we can evaluate.

Does the science back this up?

Follistatin is not a growth hormone, and calling it one, even loosely, misrepresents what it actually does. That said, it does have real and well-studied biological effects worth understanding.

Follistatin is an endogenous glycoprotein that functions primarily as a binding and neutralizing protein for myostatin, a member of the TGF-beta superfamily that inhibits muscle growth. When follistatin binds myostatin, it prevents myostatin from suppressing muscle protein synthesis. Lee and McPherron (2001, PNAS) showed that follistatin overexpression in mice produced dramatic muscle hypertrophy, roughly double normal muscle mass. That study is the one that lit the internet on fire and never really went out.

Follistatin also binds activin, another TGF-beta family member involved in reproductive regulation, inflammation, and metabolism. This is relevant because exogenous follistatin does not act like a growth hormone. It does not stimulate GH secretion, does not bind GH receptors, and does not trigger IGF-1 release through the same pathways. Conflating the two is a significant oversimplification.

What did they get wrong (or right)?

Framing follistatin as a "growth hormone" type compound gets the mechanism wrong, though the outcome, more muscle, is directionally accurate in animal models. Follistatin works by releasing a brake on muscle growth, not by pressing the accelerator the way GH or IGF-1 does. That distinction matters clinically and mechanistically.

What the fitness community often gets right is that follistatin levels are genuinely associated with muscle mass and recovery capacity. Rodino-Klapac et al. (2009, Journal of Translational Medicine) demonstrated that intramuscular delivery of follistatin gene constructs increased muscle size and strength in primates. That is real data. But gene therapy in a primate study is a long way from someone injecting a peptide vial bought online.

The omega-3 connection mentioned in the caption is actually more interesting than it sounds. Some research suggests omega-3 fatty acids may modestly influence follistatin expression, but the effect sizes in human studies are small and the clinical relevance is unclear. Calling omega-3 a follistatin booster would be a stretch.

What should you actually know?

Follistatin as an exogenous therapeutic is not approved by the FDA for any indication. Recombinant follistatin products exist in research contexts, but they are not regulated peptide therapeutics available through legitimate compounding pharmacies for general use. If someone is selling you "follistatin peptide" for injection, you should ask hard questions about what exactly is in that vial and where it was manufactured.

The myostatin-inhibition pathway is a legitimate area of pharmaceutical research. Drugs like bimagrumab (an anti-activin receptor antibody) and apitegromab (anti-myostatin) are in clinical trials for muscle-wasting diseases. These are carefully dosed, monitored compounds in controlled settings, not gym supplements.

• Follistatin is not growth hormone and does not work like it
• Animal data showing muscle hypertrophy is real but does not translate directly to injectable peptide use in humans
• No exogenous follistatin product is FDA-approved or legally available through regulated telehealth channels
• Anyone combining unregulated follistatin with other compounds is operating without any safety data